CytMesh Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
CytMesh General Information
Description
Developer of a lab test platform intended to extract undetectable metastatic circulating tumor cells present in the bloodstream and cerebrospinal fluid samples of cancer patients. The company is currently operating in Stealth mode.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
- Atlanta, GA
- United States
Primary Industry
Diagnostic Equipment
Other Industries
Other Commercial Services
Other Commercial Products
Vertical(s)
Corporate Office
- Atlanta, GA
- United States
CytMesh Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 24-Jun-2025 | Completed | Stealth |
CytMesh Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biolocity | Accelerator/Incubator |
CytMesh FAQs
-
Where is CytMesh headquartered?
CytMesh is headquartered in Atlanta, GA.
-
What industry is CytMesh in?
CytMesh’s primary industry is Diagnostic Equipment.
-
Is CytMesh a private or public company?
CytMesh is a Private company.
-
What is CytMesh’s current revenue?
The current revenue for CytMesh is .
-
Who are CytMesh’s investors?
Biolocity has invested in CytMesh.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process